Pingyangmycin
Clinical data | |
---|---|
Other names | Bleomycin A5 |
Pregnancy category |
|
intramuscular, intratumoral | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | amidase |
Elimination half-life | 1.3 hours |
Excretion | renal (25-50%) |
Identifiers | |
| |
JSmol) | |
| |
|
Pingyangmycin (also known as bleomycin A5) is an
In China, pingyangmycin has largely superseded bleomycin A2 (commonly known as "bleomycin"), since according to Chinese sources it is more effective, costs less, is easier to get, can treat a larger variety of
anaphylactic shock, which is rare, but may happen even in a low dose, and can be fatal.[4] In addition, it causes a higher incidence of fever
than bleomycin; the occurrence of this complication in patients is between 20 and 50%.